TGFBR1 and colorectal carcinoma: As allele-specific expression of TGFBR1 has the potential to be used in the clinical evaluation of CRC risk, the aim of this study was to further investigate the extent of ASE of TGFBR1 in CRC using the robust and specific pyrosequencing technique for ASE determination.